发明授权
- 专利标题： Hydroxamates as therapeutic agents
- 专利标题（中）： 羟肟酸盐作为治疗剂
-
申请号： US12896535申请日： 2010-10-01
-
公开(公告)号： US08026371B2公开(公告)日： 2011-09-27
- 发明人: Erik J. Verner , Martin Sendzik , Chitra Baskaran , Joseph J. Buggy , James Robinson
- 申请人： Erik J. Verner , Martin Sendzik , Chitra Baskaran , Joseph J. Buggy , James Robinson
- 申请人地址： US CA Sunnyvale
- 专利权人： Pharmacyclics, Inc.
- 当前专利权人： Pharmacyclics, Inc.
- 当前专利权人地址： US CA Sunnyvale
- 代理机构： Wilson Sonsini Goodrich & Rosati
- 主分类号： C07D263/54
- IPC分类号： C07D263/54 ; A61K31/42
摘要：
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
公开/授权文献
- US20110021528A1 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS 公开/授权日：2011-01-27
信息查询
